Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
March 2024
View This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2024
View This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
TS SciComm
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Webinars
ADVERTISEMENT
Home
Subjects
genetics & genomics, clinical trials
genetics & genomics, clinical trials
23andMe Partners with Pfizer
Jef Akst
| Jan 13, 2015
| 1 min read
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
The Year in Pathogens
Molly Sharlach
| Dec 28, 2014
| 4 min read
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
Statins Stimulate Bone Growth?
Kate Yandell
| Sep 17, 2014
| 3 min read
The cholesterol-lowering drugs could be used to treat people with two types of dwarfism, a study suggests.
Week in Review: June 16–20
Tracy Vence
| Jun 20, 2014
| 2 min read
Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors
Week in Review: May 5–9
Tracy Vence
| May 8, 2014
| 4 min read
Synthetic base pairs replicated in vivo; cardiac stem cells questioned; miniature neurotransmissions and synaptic development; neurogenesis and memory loss; STAP saga continues
Opinion: Overcoming Cancer’s Complexities
Daniel S. Kapp, David Rubenson, and Beverly Mitchell
| Apr 11, 2014
| 4 min read
Considering “targeted therapeutics” in the face of intra-patient heterogeneity.
The Right to Know—or Not
Tracy Vence
| Dec 12, 2013
| 2 min read
Consumers, patients, and study participants should be made aware of potential incidental findings, according to a federally-appointed bioethics panel.
Pharmacogenetics Puzzle
Tracy Vence
| Nov 20, 2013
| 2 min read
Conflicting clinical trial results leave researchers unsure whether genetic information is useful for determining initial Warfarin dosage.
Virus Versus Bacteria
Edyta Zielinska
| Apr 17, 2013
| 1 min read
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
Cancer Clinical Trials of Tomorrow
Tomasz M. Beer
| Apr 1, 2013
| 4 min read
Advances in genomics and cancer biology will alter the design of human cancer studies.
Making Cancer More Transparent
Mary Beth Aberlin
| Apr 1, 2013
| 3 min read
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
More Oversight for Omics Tests
N/A
| Mar 27, 2012
| 1 min read
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
My DNA, My Results
Cristina Luiggi
| Mar 22, 2012
| 1 min read
Are donors of biological material privy to research results that stem from their donation?
Regulating the Humanized
Bob Grant
| Jul 25, 2011
| 1 min read
A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.
The ghost of personalized medicine
Bob Grant
| Jun 14, 2011
| 4 min read
Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic.
ADVERTISEMENT